Trulieve Cannabis (TRLV) Invested Capital (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Invested Capital for 7 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Invested Capital fell 5.71% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 5.71% YoY), while the FY2025 annual figure was $1.2 billion, down 8.17% from the prior year.
• Invested Capital came in at $1.1 billion for Q1 2026 at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
• The five-year high for Invested Capital was $2.1 billion in Q2 2022, with the low at $1.1 billion in Q1 2026.
• Average Invested Capital over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2024.
• Across the five-year window, Invested Capital jumped 339.27% in 2022 and tumbled 31.75% in 2023, its largest moves.
• Year by year, Invested Capital stood at $2.0 billion in 2022, then fell by 24.69% to $1.5 billion in 2023, then dropped by 10.26% to $1.3 billion in 2024, then fell by 8.17% to $1.2 billion in 2025, then decreased by 5.63% to $1.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.